Behavioral
Trigg County Hospital, INC
Trigg County Hospital, INC was paid $7.96M by Medicaid between Jan 2018 and Nov 2024, across 118 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.
33Billing provider infoTRIGG COUNTY HOSPITAL, INC
CADIZ, KY 42211
CADIZ, KY 42211
33aNPI1538218680assigned 01/09/2007
33bProvider typeClinical Social Worker
28Total paid$7.96M
24GClaims159,257
24DCodes billed118
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Social Worker providers in Kentucky
Rank by total paid#8 of 275
Median peer was paid$57K
This provider vs. median139×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,811 | $1.26M | |
| 2019 | 23,067 | $1.13M | |
| 2020 | 19,180 | $1.00M | |
| 2021 | 26,676 | $1.21M | |
| 2022 | 21,437 | $1.27M | |
| 2023 | 19,672 | $1.19M | |
| 2024incomplete | 15,414 | $884K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 8,397 | 6,385 | $817K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.7% | 10,674 | 8,883 | $770K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.2% | 493 | 427 | $733K |
| 80053 | Comprehensive metabolic panel | 7.8% | 10,958 | 8,817 | $618K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.8% | 6,760 | 1,060 | $462K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.6% | 617 | 479 | $447K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.4% | 1,129 | 826 | $353K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.4% | 1,916 | 1,315 | $269K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 3.2% | 10,230 | 974 | $258K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 10,222 | 7,783 | $212K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.6% | 2,684 | 1,651 | $204K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 2,442 | 1,893 | $187K |
106 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 3,344 | $179K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 2,436 | $167K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 2,420 | $152K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 2,492 | $151K |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 18,587 | $134K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 2,573 | $125K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 1,205 | $124K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 2,249 | $115K |
| 80061 | Lipid panel | 1.4% | 3,230 | $113K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.3% | 730 | $104K |
| 90837 | Psychotherapy session, about an hour | 1.1% | 2,382 | $85K |
| 99285 | Emergency room visit (most serious) | <1% | 486 | $75K |
| 80306 | <1% | 2,036 | $72K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,107 | $72K |
| 84484 | <1% | 2,279 | $71K | |
| 99284 | Emergency room visit (serious) | <1% | 821 | $70K |
| 87088 | <1% | 2,597 | $70K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,946 | $59K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,510 | $56K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,825 | $51K |
| 81001 | <1% | 3,561 | $44K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 826 | $41K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,399 | $36K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,106 | $29K |
| 83735 | <1% | 1,584 | $27K | |
| 83690 | <1% | 1,898 | $25K | |
| 81003 | <1% | 3,253 | $22K | |
| 81025 | <1% | 878 | $22K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,450 | $19K |
| 72100 | <1% | 185 | $18K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 702 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 493 | $16K |
| 82150 | <1% | 751 | $16K | |
| 97161 | <1% | 255 | $15K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 129 | $14K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,809 | $14K |
| 73630 | <1% | 133 | $13K | |
| 87077 | <1% | 625 | $13K | |
| 87186 | <1% | 490 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 470 | $11K |
| 85610 | <1% | 718 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,263 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 611 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 835 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,075 | $7K |
| 73610 | <1% | 59 | $6K | |
| 85730 | <1% | 316 | $5K | |
| 83880 | <1% | 102 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 23 | $5K |
| 82607 | <1% | 184 | $5K | |
| 0012A | <1% | 262 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 173 | $5K |
| 73030 | <1% | 53 | $4K | |
| 85378 | <1% | 72 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 17 | $4K |
| J2704 | Injection, propofol, 10 mg | <1% | 253 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 135 | $4K |
| 0011A | <1% | 287 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 117 | $3K |
| 80305 | <1% | 146 | $3K | |
| 84439 | <1% | 152 | $3K | |
| 82043 | <1% | 285 | $3K | |
| 72110 | <1% | 20 | $3K | |
| 87634 | <1% | 52 | $3K | |
| 83605 | <1% | 125 | $2K | |
| 90734 | <1% | 17 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $2K |
| 86757 | <1% | 24 | $2K | |
| 85652 | <1% | 91 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 143 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 326 | $2K |
| 0013A | <1% | 60 | $1K | |
| 73130 | <1% | 17 | $1K | |
| 83874 | <1% | 29 | $1K | |
| 90688 | <1% | 86 | $1K | |
| 80320 | <1% | 53 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 44 | $1K |
| 90633 | <1% | 27 | $1K | |
| 87807 | <1% | 28 | $991.28 | |
| 0002A | <1% | 33 | $974.77 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 122 | $955.04 |
| 90694 | <1% | 14 | $929.68 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 59 | $914.18 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 67 | $883.14 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $795.13 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $792.13 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 27 | $774.34 |
| 90674 | <1% | 23 | $759.32 | |
| 84702 | <1% | 15 | $734.11 | |
| 86738 | <1% | 21 | $559.31 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 184 | $444.84 |
| 96376 | <1% | 20 | $426.30 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $385.45 |
| 0001A | <1% | 25 | $338.14 | |
| 82803 | <1% | 19 | $306.98 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 57 | $297.74 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 170 | $266.05 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 17 | $265.41 |
| 36600 | <1% | 19 | $204.18 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 21 | $178.28 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 36 | $32.04 |
| 91301 | <1% | 705 | $20.34 | |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | <1% | 18 | $4.17 |
| A9270 | Non-covered item or service | 0% | 371 | $0.00 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 0% | 15 | $0.00 |
| 91300 | 0% | 66 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUMNER, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Trigg County Hospital INC. | Cadiz, KY | $231K |
| Trigg County Hospital, INC | Cadiz, KY | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.